AVITA Medical, Inc. (RCEL)
15.60
-0.60
(-3.70%)
USD |
NASDAQ |
Nov 13, 16:00
15.60
0.00 (0.00%)
After-Hours: 19:59
AVITA Medical Net Income (Quarterly) : -6.222M for Sept. 30, 2026
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | -6.222M |
| June 30, 2026 | -7.663M |
| March 31, 2026 | -10.61M |
| December 31, 2025 | -11.62M |
| September 30, 2025 | -13.19M |
| June 30, 2025 | -9.92M |
| March 31, 2025 | -13.86M |
| December 31, 2024 | -11.59M |
| September 30, 2024 | -16.20M |
| June 30, 2024 | -15.39M |
| March 31, 2024 | -18.66M |
| December 31, 2023 | -7.065M |
| Date | Value |
|---|---|
| September 30, 2023 | -8.712M |
| June 30, 2023 | -10.38M |
| March 31, 2023 | -9.22M |
| December 31, 2022 | -5.353M |
| September 30, 2022 | -5.588M |
| June 30, 2022 | -6.261M |
| March 31, 2022 | -9.463M |
| June 30, 2021 | -4.718M |
| March 31, 2021 | -5.997M |
| December 31, 2020 | -5.641M |
| September 30, 2020 | -10.23M |
| June 30, 2020 | -12.91M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Iovance Biotherapeutics, Inc. | -22.27M |
| Halozyme Therapeutics, Inc. | 247.05M |
| Agenus, Inc. | 1.567M |
| Amgen, Inc. | 3.864B |
| Fate Therapeutics, Inc. | -30.69M |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 26.11M |
| Total Expenses (Quarterly) | 32.34M |
| EPS Diluted (Quarterly) | -0.2016 |
| Enterprise Value | 538.23M |
| Gross Profit Margin (Quarterly) | 84.02% |
| Profit Margin (Quarterly) | -23.83% |
| Earnings Yield | -7.57% |
| Normalized Earnings Yield | -8.165 |